Tine B. Stensbol
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Differential resting-state patterns across networks are spatially associated with Comt and Trmt2a gene expression patterns in a mouse model of 22q11.2 deletion.
Journal: NeuroImage
Published: May 11, 2021
Separable neural mechanisms for the pleiotropic association of copy number variants with neuropsychiatric traits.
Journal: Translational psychiatry
Published: October 09, 2019
The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT3 receptor expressing interneurons: An in vitro study in rat hippocampus slices.
Journal: Brain research
Published: July 16, 2017
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.
Journal: Journal of psychiatry & neuroscience : JPN
Published: July 09, 2016
Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: July 03, 2016
New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III.
Journal: Journal of medicinal chemistry
Published: January 28, 2016
An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 24, 2016
A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.
Journal: Psychopharmacology
Published: January 06, 2016
The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
Journal: Expert review of neurotherapeutics
Published: September 25, 2015
Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulator.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 21, 2014
Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 21, 2014
Last Updated: 09/26/2026